Clinical features of patients with AS and the control group
| Mild AS (AVA >1.5 cm2) (66) | Moderate AS (AVA 1.0–1.5 cm2) (47) | Severe AS (AVA <1.0 cm2) (32) | Control group (283) | P value | |
| Mean age, years | 84±7.5 | 83±9.2 | 87±5.8 | 83±8 | NS |
| Fracture type, n (%) | |||||
| Femoral neck | 33 (50) | 24 (51.1) | 18 (56.3) | 131 (46.3) | NS |
| Pertrochanteric | 31 (47) | 20 (42.6) | 14 (43.7) | 136 (48.1) | |
| Intertrochanteric | 2 (3) | 3 (6.4) | 0 | 16 (5.6) | |
| Heart failure | 8 (12.1) | 13 (27.7) | 8 (25) | 30 (10.6) | 0.011 |
| Renal insufficiency | 2 (3) | 5 (10.6) | 2 (6.3) | 5 (15.6) | 0.013 |
| COPD | 4 (6) | 9 (19.1) | 3 (9.4) | 28 (10) | NS |
| CAD | 17 (25.8) | 12 (25.5) | 5 (15.6) | 41 (14.4) | 0.023 |
| Atrial fibrillation Arterial hypertension | 15 (22.7) 48 (72) | 14 (29.8) 35 (74) | 13 (40.6) 23 (71) | 25 (8.8) 215 (75) | <0.0001 NS |
| BADL ≤4 | 43 (65.2) | 33 (70.2) | 13 (40.6) | 75 (26.5) | 0.002 |
| Functional impairment | 11 (16.7) | 28 (38.3) | 14 (43.8) | 127 (44.9) | NS |
| Parkinson’s | 12 (18.2) | 5 (10.6) | 2 (6.3) | 16 (5.6) | 0.014 |
| Cognitive impairment | 11 (16.7) | 10 (21.3) | 10 (31.3) | 95 (33.6) | 0.009 |
AS, aortic stenosis; AVA, aortic valve area; BADL, basic activities of daily living; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease.